Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
<p><strong>Objectives</strong></p><p>Treat to target recommendations for PsA state that the target of treatment should be remission or, at the very least, low disease activity. Different clinical indexes have been proposed to define these disease states including the mi...
Үндсэн зохиолчид: | Coates, L, Rahman, P, Psaradellis, E, Rampakakis, E, Osborne, B, Lehman, A, Nantel, F |
---|---|
Формат: | Journal article |
Хэвлэсэн: |
Oxford University Press
2018
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry
-н: Emmanouil Rampakakis, зэрэг
Хэвлэсэн: (2020-08-01) -
Golimumab for the treatment of psoriatic arthritis
-н: H Yang, зэрэг
Хэвлэсэн: (2011-05-01) -
Golimumab in the treatment of psoriatic arthritis: efficacy and safety
-н: Tatiana Viktorovna Korotaeva, зэрэг
Хэвлэсэн: (2015-09-01) -
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
-н: Proton Rahman, зэрэг
Хэвлэсэн: (2020-09-01) -
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
-н: M. Rossini, зэрэг
Хэвлэсэн: (2015-03-01)